Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Sunday, May 4 • 10:00am - 11:30am
New Cancer Drug Update 2013/2014

Sign up or log in to save this to your schedule and see who's attending!

Are you familiar with the new cancer drugs that the FDA has approved within the last year? Gain an introduction to these novel treatments while learning helpful tips to help you quickly grasp drug classifications. Presenter Teresa Knoop, MSN, RN, AOCN®, CCRP, will walk you through the multidisciplinary trends in drug development, discuss the newly approved molecular and radiotherapeutic agents, and share future directions for cancer therapies. 

OBJECTIVES

1. Identify new drugs that have been FDA-approved for cancer treatment in 2013 and 2014.
2. Recognize how new drugs are given generic names.
3. Identify how to gain information about new drugs based on the generic naming system.

ILNA
This session qualifies for the following ONCC Individual Learning Needs Assessment (ILNA) categories.

OCN®: Scientific Basis for Practice, Treatment Modalities
CBCN®: Treatment Modalities:  Local and Systemic, Professional Performance
AOCNP®: Cancer Treatment
AOCNS®: Cancer Treatment

 

Speakers
avatar for Teresa Knoop, MSN, RN, AOCN®, CCRP

Teresa Knoop, MSN, RN, AOCN®, CCRP

Assistant Director, Clinical Trials Shared Resource, Vanderbilt-Ingram Cancer Center
Teresa Knoop is an Assistant Director at the Vanderbilt-Ingram Cancer Center in Nashville, TN, where she supervises the Clinical Trials Information Program. The program serves as the referral center for Phase I, II, and III trials at the center and provides healthcare professionals and consumers with services, specialists, and second opinions. Knoop also directs special projects related to clinical research integration and Phase I program... Read More →



Sunday May 4, 2014 10:00am - 11:30am
Arena Anaheim Convention Center, 800 W. Katella Avenue. Anaheim, CA 92802